CS511987A2 - Method of new diphenylamine derivatives production - Google Patents

Method of new diphenylamine derivatives production

Info

Publication number
CS511987A2
CS511987A2 CS875119A CS511987A CS511987A2 CS 511987 A2 CS511987 A2 CS 511987A2 CS 875119 A CS875119 A CS 875119A CS 511987 A CS511987 A CS 511987A CS 511987 A2 CS511987 A2 CS 511987A2
Authority
CS
Czechoslovakia
Prior art keywords
denotes
denotes hydrogen
hydrogen
benzyloxy
chlorine
Prior art date
Application number
CS875119A
Other languages
English (en)
Other versions
CS271343B2 (en
Inventor
Dezso Dr Ing Korbonits
Pal Dr Ing Kiss
Laszlo Dr Szekeres
Gyula Dr Papp
Gabor Dr Ing Kovacs
Andrea Ing Santa
Sandor Dr Virag
Eva Dr Udvari
Imre Ing Bata
Katalin Ing Marmarosi
Laszlo Dr Tardos
Peter Dr Kormoczy
Vera Dr Gerely
Zoltan Dr Vargai
Original Assignee
Chinoin Gyogyszer Es Vegyeszet
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chinoin Gyogyszer Es Vegyeszet filed Critical Chinoin Gyogyszer Es Vegyeszet
Publication of CS511987A2 publication Critical patent/CS511987A2/cs
Publication of CS271343B2 publication Critical patent/CS271343B2/cs

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
    • C07D317/50—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to atoms of the carbocyclic ring
    • C07D317/58—Radicals substituted by nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C211/00—Compounds containing amino groups bound to a carbon skeleton
    • C07C211/01—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms
    • C07C211/16—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of a saturated carbon skeleton containing rings other than six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C211/00—Compounds containing amino groups bound to a carbon skeleton
    • C07C211/01—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms
    • C07C211/26—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing at least one six-membered aromatic ring
    • C07C211/27—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing at least one six-membered aromatic ring having amino groups linked to the six-membered aromatic ring by saturated carbon chains
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C211/00—Compounds containing amino groups bound to a carbon skeleton
    • C07C211/01—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms
    • C07C211/26—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing at least one six-membered aromatic ring
    • C07C211/29—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing at least one six-membered aromatic ring the carbon skeleton being further substituted by halogen atoms or by nitro or nitroso groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/54—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C217/56—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by singly-bound oxygen atoms
    • C07C217/58—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by singly-bound oxygen atoms with amino groups and the six-membered aromatic ring, or the condensed ring system containing that ring, bound to the same carbon atom of the carbon chain
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/34—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups
    • C07C233/42—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by a carbon atom of a six-membered aromatic ring
    • C07C233/43—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by a carbon atom of a six-membered aromatic ring having the carbon atom of the carboxamide group bound to a hydrogen atom or to a carbon atom of a saturated carbon skeleton

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Obesity (AREA)
  • Vascular Medicine (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Indole Compounds (AREA)
CS875119A 1986-07-11 1987-07-06 Method of new diphenylamine derivatives production CS271343B2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU862873A HU200591B (en) 1986-07-11 1986-07-11 Process for producing new diphenyl propylamine derivatives and pharmaceutical compositions comprising such compounds

Publications (2)

Publication Number Publication Date
CS511987A2 true CS511987A2 (en) 1989-08-14
CS271343B2 CS271343B2 (en) 1990-09-12

Family

ID=55982790

Family Applications (1)

Application Number Title Priority Date Filing Date
CS875119A CS271343B2 (en) 1986-07-11 1987-07-06 Method of new diphenylamine derivatives production

Country Status (28)

Country Link
US (1) US4988730A (cs)
EP (1) EP0253327B1 (cs)
JP (1) JP2637737B2 (cs)
KR (1) KR910000864B1 (cs)
CN (1) CN1019571B (cs)
AT (1) ATE75722T1 (cs)
AU (1) AU599117B2 (cs)
CA (1) CA1335104C (cs)
CS (1) CS271343B2 (cs)
DD (1) DD263980A5 (cs)
DE (1) DE3778770D1 (cs)
DK (1) DK360187A (cs)
ES (1) ES2032778T3 (cs)
FI (1) FI95128C (cs)
GR (1) GR3004518T3 (cs)
HR (1) HRP930508A2 (cs)
HU (1) HU200591B (cs)
IE (1) IE60028B1 (cs)
IL (1) IL83044A (cs)
NO (1) NO167658C (cs)
NZ (1) NZ221036A (cs)
PH (1) PH24514A (cs)
PL (1) PL150887B1 (cs)
PT (1) PT85304B (cs)
SI (1) SI8711299A8 (cs)
SU (2) SU1597096A3 (cs)
YU (1) YU46559B (cs)
ZA (1) ZA874812B (cs)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1205124B (it) * 1987-06-05 1989-03-15 Simens Soteta Italiana Medicin Composto attivo nella terapia carciovascolare
GB8823203D0 (en) * 1988-10-04 1988-11-09 Pfizer Ltd Therapeutic agents
JPH04329415A (ja) * 1991-04-30 1992-11-18 Fujitsu Ltd カード型入出力インタフェース装置及びシステム
US5688938A (en) * 1991-08-23 1997-11-18 The Brigham & Women's Hospital, Inc. Calcium receptor-active molecules
US6031003A (en) * 1991-08-23 2000-02-29 Nps Pharmaceuticals, Inc. Calcium receptor-active molecules
US6313146B1 (en) 1991-08-23 2001-11-06 Nps Pharmaceuticals, Inc. Calcium receptor-active molecules
DE69233572T2 (de) * 1991-08-23 2006-08-31 NPS Pharmaceuticals, Inc., Salt Lake City Screening-Verfahren für Kalzium-Rezeptor aktive Verbindungen
US5858684A (en) * 1991-08-23 1999-01-12 The Brigham And Women's Hospital, Inc. Method of screening calcium receptor-active molecules
US5763569A (en) * 1991-08-23 1998-06-09 The Brigham And Women's Hospital, Inc Calcium receptor-active molecules
US6011068A (en) * 1991-08-23 2000-01-04 Nps Pharmaceuticals, Inc. Calcium receptor-active molecules
US6001884A (en) * 1991-08-23 1999-12-14 Nps Pharmaceuticals, Inc. Calcium receptor-active molecules
US5198548A (en) * 1992-01-30 1993-03-30 Warner-Lambert Company Process for the preparation of D(-) and L(+)-3,3-diphenylalanine and D(-) and L(+)-substituted 3,3-diphenylalanines and derivatives thereof
US6071970A (en) * 1993-02-08 2000-06-06 Nps Pharmaceuticals, Inc. Compounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders and diseases
US5962314A (en) * 1993-02-23 1999-10-05 Nps Pharmaceuticals, Inc. Calcium receptor-active molecules
KR100296899B1 (ko) * 1993-02-23 2001-10-24 쉘비 칼베르그 모르스 칼슘수용체활성분자
US5492933A (en) * 1993-10-08 1996-02-20 Sepracor, Inc. Methods and compositions for treating urinary incontinence and other disorders using optically pure R-terodiline and hydroxylated derivatives thereof
ES2285707T3 (es) 1994-10-21 2007-11-16 Nps Pharmaceuticals, Inc. Compuestos activos frente al receptor de calcio.
ATE430123T1 (de) 1996-05-01 2009-05-15 Nps Pharma Inc Inorganische am ionen-rezeptor aktive verbindungen
SE9701144D0 (sv) * 1997-03-27 1997-03-27 Pharmacia & Upjohn Ab Novel compounds, their use and preparation
US6124507A (en) 1997-12-10 2000-09-26 Union Carbide Chemicals & Plastics Technology Corporation Electron donors
EP0957073A1 (en) * 1998-05-12 1999-11-17 Schwarz Pharma Ag Novel derivatives of 3,3-diphenylpropylamines
DE10315917A1 (de) * 2003-04-08 2004-11-18 Schwarz Pharma Ag Hochreine Basen von 3,3-Diphenylpropylaminmonoestern
FR2902789A1 (fr) * 2006-06-21 2007-12-28 Genfit Sa Derives de 1,3-diphenylpropane substitues, preparations et utilisations

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1171930B (de) * 1961-08-10 1964-06-11 Chinoin Gyogyszer Es Vegyeszet Verfahren zur Herstellung von koronardilatent wirksamen substituierten Propylaminderivaten
CH462189A (de) * 1961-08-10 1968-09-15 Chinoin Gyogyszer Es Vegyeszet Verfahren zur Herstellung von substituierten Propylaminderivaten
GB1032650A (en) * 1962-05-24 1966-06-15 Chinoin Gyogyszer Es Vegyeszet Improvements in or relating to diphenyl-propylamine derivatives
DD122967A1 (de) * 1975-07-10 1976-11-12 Lothar Luecke Hylamin-derivate

Also Published As

Publication number Publication date
IL83044A0 (en) 1987-12-31
US4988730A (en) 1991-01-29
JP2637737B2 (ja) 1997-08-06
PL150887B1 (en) 1990-07-31
FI95128C (fi) 1995-12-27
ES2032778T3 (es) 1993-03-01
IE60028B1 (en) 1994-05-18
HU200591B (en) 1990-07-28
NZ221036A (en) 1990-05-28
NO872880L (no) 1988-01-12
NO167658B (no) 1991-08-19
HUT46651A (en) 1988-11-28
FI873069A7 (fi) 1988-01-12
IE871866L (en) 1988-01-11
FI95128B (fi) 1995-09-15
HRP930508A2 (en) 1995-02-28
ATE75722T1 (de) 1992-05-15
NO167658C (no) 1991-11-27
YU46559B (sh) 1993-11-16
EP0253327B1 (de) 1992-05-06
CS271343B2 (en) 1990-09-12
SU1597096A3 (ru) 1990-09-30
DK360187A (da) 1988-01-12
KR880001573A (ko) 1988-04-25
SU1588740A1 (ru) 1990-08-30
ZA874812B (en) 1988-10-26
CN1019571B (zh) 1992-12-23
CA1335104C (en) 1995-04-04
PT85304A (en) 1987-08-01
AU7552687A (en) 1988-01-14
NO872880D0 (no) 1987-07-10
PL266759A1 (en) 1988-09-01
GR3004518T3 (cs) 1993-04-28
SI8711299A8 (en) 1996-08-31
PT85304B (pt) 1990-03-30
DD263980A5 (de) 1989-01-18
CN87104753A (zh) 1988-06-15
AU599117B2 (en) 1990-07-12
EP0253327A2 (de) 1988-01-20
PH24514A (en) 1990-07-18
FI873069A0 (fi) 1987-07-10
DE3778770D1 (de) 1992-06-11
JPS6372657A (ja) 1988-04-02
KR910000864B1 (ko) 1991-02-11
DK360187D0 (da) 1987-07-10
EP0253327A3 (en) 1988-11-30
IL83044A (en) 1991-09-16
YU129987A (en) 1988-06-30

Similar Documents

Publication Publication Date Title
CS511987A2 (en) Method of new diphenylamine derivatives production
DK0490772T3 (da) 1,4-disubstituerede piperaziner, fremgangsmåde til fremstilling heraf og farmaceutiske midler, der indeholder dem
ES2139638T3 (es) 1,4-piperazinas disustituidas para el tratamiento de las enfermedades del sistema nervioso central y de las enfermedades neuroendocrinas.
MX9201014A (es) Composicion farmaceutica para disminuir el nivel de colesterol en plasma.
ES8505379A1 (es) Un metodo de fabricar 1, 4-dihidropiridina-3-carboxilatos
AU555818B2 (en) Amino hydroxy proprophenones pharmaceutical use
DK408083D0 (da) Isoquinilinderivater, deres fremstilling og anvendelse
PT100415A (pt) Novas morfolinas de accao farmaceutica, e processo para a sua preparacao
DK225985A (da) Cephalosporiner eller farmaceutisk acceptable salte deraf, deres fremstilling og anvendelse som laegemidler
LV11524A (lv) Benzidamina izmantosana TNF izsaukto patologisko stavoklu arstesana
PH24258A (en) Substituted quinoxyalyl-imidazolidine-2,4-diones,their use as medicaments and pharmaceutical preparation
IL85229A0 (en) Novel imidazo-and triazolothiadiazines,a process for the preparation thereof,pharmaceutical compositions containing same,and the use thereof
EE02938B1 (et) p-hüdroksübensoehappe derivaadid, nende valmistamismeetod ja kasutamine ravimitena
DE3778858D1 (de) 17-benzylspartein-derivate enthaltende positiv inotrop wirksame pharmazeutische zubereitungen.
DK214884D0 (da) Chlorphenoxyacetatderivat